We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$4.09B
AUM Growth
+$102M
Cap. Flow
+$32.6M
Cap. Flow %
0.8%
Top 10 Hldgs %
13.53%
Holding
1,203
New
85
Increased
521
Reduced
524
Closed
70

Sector Composition

Rank Sector Weight
1 Financials 14.95%
2 Technology 14.83%
3 Healthcare 13.43%
4 Industrials 10.8%
5 Consumer Discretionary 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSG icon
126
Republic Services
RSG
$63.9B
$8.19M 0.2%
119,813
+48,561
+68% +$3.27M
ADI icon
127
Analog Devices
ADI
$184B
$8.09M 0.2%
84,333
+7,207
+9% +$680K
KNX icon
128
Knight Transportation
KNX
$11.5B
$8.03M 0.2%
210,153
+94,389
+82% +$3.89M
ORCL icon
129
Oracle
ORCL
$416B
$8.02M 0.2%
181,997
-27,981
-13% -$1.29M
EW icon
130
Edwards Lifesciences
EW
$51.3B
$7.98M 0.2%
164,394
-35,799
-18% -$1.67M
TJX icon
131
TJX Companies
TJX
$177B
$7.97M 0.19%
167,424
-4,784
-3% -$210K
FIVE icon
132
Five Below
FIVE
$12.4B
$7.95M 0.19%
81,350
+1,035
+1% +$83.1K
ULTA icon
133
Ulta Beauty
ULTA
$23.2B
$7.94M 0.19%
34,002
-665
-2% -$161K
NVDA icon
134
NVIDIA
NVDA
$5.31T
$7.84M 0.19%
1,324,080
+15,640
+1% +$95K
DOC icon
135
Healthpeak Properties
DOC
$15B
$7.75M 0.19%
300,147
+7,400
+3% +$174K
SPGI icon
136
S&P Global
SPGI
$121B
$7.73M 0.19%
37,897
-669
-2% -$132K
DAR icon
137
Darling Ingredients
DAR
$9.19B
$7.72M 0.19%
388,289
-103,865
-21% -$1.88M
SNY icon
138
Sanofi
SNY
$104B
$7.65M 0.19%
191,244
+3,065
+2% +$121K
AMGN icon
139
Amgen
AMGN
$221B
$7.63M 0.19%
41,306
+645
+2% +$114K
ULTI
140
DELISTED
Ultimate Software Group Inc
ULTI
$7.58M 0.19%
29,468
-164
-0.6% -$42.1K
APD icon
141
Air Products & Chemicals
APD
$65.7B
$7.47M 0.18%
48,002
+3,975
+9% +$650K
BKNG icon
142
Booking.com
BKNG
$156B
$7.45M 0.18%
91,900
+9,300
+11% +$783K
VRSK icon
143
Verisk Analytics
VRSK
$24.6B
$7.32M 0.18%
68,016
+7,213
+12% +$768K
PRLB icon
144
Protolabs
PRLB
$2.16B
$7.32M 0.18%
61,512
+3,904
+7% +$478K
THO icon
145
Thor Industries
THO
$4.14B
$7.24M 0.18%
74,321
-5,426
-7% -$554K
AMT icon
146
American Tower
AMT
$78.3B
$7.18M 0.18%
49,781
+13,916
+39% +$1.93M
ANSS
147
DELISTED
Ansys
ANSS
$7.15M 0.18%
41,070
+1,770
+5% +$295K
SBUX icon
148
Starbucks
SBUX
$121B
$7.11M 0.17%
145,497
-31,751
-18% -$1.8M
XLY icon
149
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23B
$7.01M 0.17%
128,188
+12,478
+11% +$659K
PNFP icon
150
Pinnacle Financial Partners Inc
PNFP
$16.2B
$6.95M 0.17%
113,220
+101,013
+828% +$6.56M

Similar funds

Oppenheimer Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, Oppenheimer Asset Management held 1,203 positions worth $4.09B, up 2.6% from $3.99B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer Asset Management's Q2 2018 filing shows 85 new, 521 increased, 524 reduced and 70 closed positions. Its largest new stake was Patterson-UTI: 274,595 shares worth $4.94M. The largest sale was Advance Auto Parts, an estimated $22.3M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.

  • Oppenheimer Asset Management's largest Q2 2018 buy was Patterson-UTI: 274,595 shares worth $4.94M.
  • Oppenheimer Asset Management added most to Walgreens Boots Alliance in Q2 2018, an estimated $10.3M increase.
  • Oppenheimer Asset Management's biggest Q2 2018 reduction was Advance Auto Parts, cutting an estimated $22.3M.
  • Oppenheimer Asset Management fully exited Envision Healthcare Holdings Inc in Q2 2018, selling an estimated $7.32M.
  • Oppenheimer Asset Management's ten largest holdings make up 14% of its $4.09B portfolio in Q2 2018.
  • Oppenheimer Asset Management opened 85 new positions and closed 70 in Q2 2018.
  • Oppenheimer Asset Management's portfolio value rose 2.6% quarter-over-quarter to $4.09B.

Based on Oppenheimer Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.